Xtalks Announces its Life Science Webinar Calendar for August 2026
Upcoming free, educational webinars from Xtalks will feature topics on clinical trials, patient recruitment and retention, drug safety, laboratory technologies, pharmaceutical manufacturing and supply chain, commercialization and HEOR and preclinical research.
Visit www.xtalks.com to see our upcoming webinars:
COMMERCIALIZATION & HEOR
DRUG SAFETY
LABORATORY TECHNOLOGY
PATIENT RECRUITMENT & RETENTION
PHARMA MANUFACTURING & SUPPLY CHAIN
PRECLINICAL RESEARCH
ABOUT XTALKS
Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x272
Email: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/xtalks-announces-its-life-science-webinar-calendar-for-august-2026-302840725.html
SOURCE Xtalks
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Implantica receives FDA approval for RefluxStop® - Opening the U.S. market
- Xinhua Silk Road: Over 2,000 young people attend cross-Strait gathering in SE China's Fuzhou
- Coway Honored at IDEA Design Awards 2026, Secures International Design 'Grand Slam'
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share